Someone with a lot of money to spend has taken a bullish stance on Revance Therapeutics RVNC.
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with RVNC, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 16 options trades for Revance Therapeutics.
This isn't normal.
The overall sentiment of these big-money traders is split between 68% bullish and 31%, bearish.
Out of all of the options we uncovered, 15 are puts, for a total amount of $506,660, and there was 1 call, for a total amount of $60,180.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $22.5 for Revance Therapeutics over the last 3 months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Revance Therapeutics options trades today is 1676.75 with a total volume of 8,926.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Revance Therapeutics's big money trades within a strike price range of $20.0 to $22.5 over the last 30 days.
Revance Therapeutics Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| RVNC | PUT | SWEEP | BULLISH | 01/19/24 | $22.50 | $67.6K | 1.3K | 1.2K |
| RVNC | CALL | TRADE | BULLISH | 01/19/24 | $20.00 | $60.1K | 480 | 207 |
| RVNC | PUT | SWEEP | BULLISH | 01/19/24 | $22.50 | $59.2K | 1.3K | 268 |
| RVNC | PUT | TRADE | NEUTRAL | 08/18/23 | $20.00 | $35.4K | 3.5K | 1.0K |
| RVNC | PUT | SWEEP | BEARISH | 01/19/24 | $22.50 | $33.2K | 1.3K | 1.5K |
Where Is Revance Therapeutics Standing Right Now?
- With a volume of 3,686,406, the price of RVNC is down -7.94% at $20.25.
- RSI indicators hint that the underlying stock may be approaching oversold.
- Next earnings are expected to be released in 90 days.
What The Experts Say On Revance Therapeutics:
- HC Wainwright & Co. has decided to maintain their Buy rating on Revance Therapeutics, which currently sits at a price target of $41.
- Morgan Stanley has decided to maintain their Equal-Weight rating on Revance Therapeutics, which currently sits at a price target of $25.
- Morgan Stanley downgraded its action to Equal-Weight with a price target of $26
- Needham has decided to maintain their Buy rating on Revance Therapeutics, which currently sits at a price target of $40.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Revance Therapeutics, Benzinga Pro gives you real-time options trades alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
